Skip Navigation

Co-Chair Bios

Jonathan S. Lewin, MD
Co-Chair, Blue Ridge Academic Health Group
Executive Vice President for Health Affairs, Emory University
Executive Director, Woodruff Health Sciences Center
CEO and Chairman of the Board, Emory Healthcare 

Jeffrey Balser

Jonathan S. Lewin, MD, is the Executive Vice President for Health Affairs, Emory University; Executive Director, Woodruff Health Sciences Center; and CEO and Chairman of the Board, Emory Healthcare. He also serves as Professor of Radiology and Imaging Sciences and Professor of Biomedical Engineering in the Emory School of Medicine and Professor of Health Policy and Management in the Rollins School of Public Health. Dr. Lewin is a national leader in academic medicine strategy and integrated health care delivery and an international scientific leader in interventional and intraoperative MRI.

Prior to his Emory appointment, Dr. Lewin served as the Martin Donner Professor and Chairman of the Russell H. Morgan Department of Radiology and Radiological Science at Johns Hopkins University and the Radiologist-in-Chief at Johns Hopkins Hospital from 2004 until 2016, with secondary appointments as Professor of Oncology, Neurosurgery, and Biomedical Engineering. From 2012-2016 he also served as Co-Chair for Strategic Planning and from 2013-2016 as Senior Vice President for Integrated Healthcare Delivery for Johns Hopkins Medicine. Before joining the faculty of Johns Hopkins, Dr. Lewin was the Director of the Division of Magnetic Resonance Imaging at University Hospitals of Cleveland and Professor and Vice Chairman for Research and Academic Affairs in the Department of Radiology at Case Western Reserve University.

Dr. Lewin received his undergraduate degree in chemistry from Brown University in 1981 and his Doctor of Medicine from Yale University in 1985. Following his internship in pediatrics at Yale-New Haven Hospital and residency in diagnostic radiology at University Hospitals of Cleveland, he completed a magnetic resonance research fellowship in Germany, a neuroradiology fellowship at the Cleveland Clinic, and additional training in head and neck radiology at the Pittsburgh Eye and Ear Hospital.

Dr. Lewin is a pioneer in interventional and intraoperative MR imaging and has published more than 200 peer-reviewed scientific manuscripts and over 70 book chapters, reviews, commentaries, and other invited papers on topics including the basic science and clinical aspects of interventional MR imaging, functional MRI, head and neck imaging, MR angiography, and the imaging of acute stroke.

Dr. Lewin holds 28 U.S. and seven international patents and has been PI or co-PI on NIH and other federal and state grants with awards of more than $54 million, as well as a co-investigator on a number of other grants and projects. He is a Fellow of the International Society for Magnetic Resonance in Medicine and of the American College of Radiology and has lectured around the world on a number of topics in magnetic resonance imaging, interventional radiology, neuroradiology, and leadership in academic medicine. He has served on numerous national committees, editorial boards, and grant review groups for foundations and the NIH, and on the task force on minimally invasive cancer therapy for the National Cancer Institute. Dr. Lewin is past president of the Society of Chairs of Academic Radiology Departments, the American Roentgen Ray Society, the Association of University Radiologists, the International Society for Strategic Studies in Radiology, and the Academy for Radiology Research.

Modern Healthcare named Dr. Lewin one of the 50 Most Influential Physicians of 2017. He was also named one of the Most Influential Atlantans of 2016, 2017, 2018, 2019, 2020 and 2021 by the Atlanta Business Chronicle; one of the 100 Most Influential Georgians of 2018, 2019, 2020 and 2021 by Georgia Trend; one of the Atlanta 500 by Atlanta Magazine in 2019, 2020, and 2021; and one of the Atlanta Business Chronicle’s Most Admired CEOs for 2020. He has received Gold Medal Awards from three professional societies for distinguished service and contributions to the field of radiology (Radiology Society of North America, the American Roentgen Ray Society, and the Association of University Radiologists), and he was the 2019 recipient of the National Medical Fellowships’ Pioneer Award. He is also a past recipient of the Radiology Research Alliance Innovation and Leadership Award, as well as the Leadership Luminary Award from the Radiology Leadership Institute of the American College of Radiology. In 2019, he was elected a Fellow of the National Academy of Inventors.

Jeffrey R. Balser, MD, PhD
Co-Chair, Blue Ridge Academic Health Group
President and CEO, Vanderbilt University Medical Center
Dean, Vanderbilt University School of Medicine

Jon Lewin

Dr. Jeffrey R. Balser is currently President and CEO of Vanderbilt University Medical Center (VUMC), reporting to an independent board of directors. He is also dean of Vanderbilt University School of Medicine, a position he has held since 2008.

Dr. Balser joined Vanderbilt in 1998 and has served as a change agent in a number of roles since that time. In 2009, he was named Vice Chancellor for Health Affairs, with executive responsibility for all health-related programs, including the hospitals, clinics, research programs, and the medical and nursing schools. He led the medical center through a period of marked service-volume growth, with major inpatient expansions of the children's hospital and the adult critical care areas, bolstered by 4% compound annual growth of outpatient visits (more than 2.1 million per year) and by the creation of region's largest, multi-state provider-led network (more than 50 hospitals and 3000 clinicians: the Vanderbilt Health Affiliated Network). In 2013-2014, he led a $230 million (8%) cost reduction across all mission areas, improving the medical center's competitive position in a rapidly evolving, price-sensitive marketplace. In coordination with the Vanderbilt Chancellor and Board of Trustees, Dr. Balser led the medical center through a restructuring process that concluded April 30, 2016, placing its clinicians, hospitals, clinics, and research and graduate medical education programs into a financially distinct, not-for-profit corporation, Vanderbilt University Medical Center.

A Vanderbilt alumnus, Dr. Balser returned to Vanderbilt in 1998 as Associate Dean for Physician Scientist Development, and soon was appointed Chair of the Department of Anesthesiology, directing one of the medical center's largest clinical service programs. He became the medical center's chief research officer in 2004, leading a period of scientific expansion that moved the medical center into the nation's top 10 in NIH funding, launching big-science programs integrating health informatics and genomics that stimulated the medical center's national leadership in personalized medicine. In 2008 he was elected to the National Academy of Medicine and later that year was named the 11th dean of Vanderbilt's School of Medicine. 

Dr. Balser received a B.S. in engineering from Tulane University in 1984 and his MD/PhD degrees (pharmacology) from Vanderbilt University in 1990. He undertook residency training in anesthesiology and fellowship training in cardiac anesthesiology and in critical care medicine at The Johns Hopkins Hospital in Baltimore. He joined the faculty at Johns Hopkins in 1995, where he practiced cardiac anesthesiology and ICU medicine and led an NIH-funded research program aimed at the genetics of cardiac rhythm disorders, such as sudden cardiac death.